Clinical trial • Phase I • Infectious Disease
Clinical trial in HIV-1 infection
Phase I trial for HIV-1 infection. open-label, none/not specified-controlled. 15 participants.
Overview
- Trial Therapeutic Area
- Infectious Disease
- Trial Disease
- HIV-1 infection
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 30-09-2024
- First CTIS Authorization Date
- 16-10-2024
Trial design
open-label, none/not specified-controlled Phase I trial across 1 site in Belgium.
- Open Label
- Yes
- Comparator
- None/Not specified
- Target Sample Size
- 15
Eligibility
Recruits 15 isVulnerablePopulationSelected: false.
- Vulnerable Population
- isVulnerablePopulationSelected: false
Recruitment
- Planned Sample Size
- 15
- Recruitment Window Months
- 47
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 15
Belgium
- Earliest CTIS Part Ii Submission Date
- 10-10-2024
- Latest Decision Or Authorization Date
- 16-02-2026
- Processing Time Days
- 494
- Number Of Sites
- 1
- Number Of Participants
- 15
Sites
- Site Name
- CHU Saint-Pierre
- Department Name
- Maladies infectieuses
- Principal Investigator Name
- Stéphane DE WIT
- Principal Investigator Email
- stephane.dewit@stpierre-bru.be
- Contact Person Name
- Stéphane DE WIT
- Contact Person Email
- stephane.dewit@stpierre-bru.be
- Number Of Participants
- 15
Sponsor
Primary sponsor
- Full Name
- ANRS Maladies Infectieuses Emergentes
- Organisation Type
- Laboratory/Research/Testing facility
- Country Of Registered Address
- France
Investigational products
- Combination Treatment
- Yes
Related trials
Other published trials that may interest you.